Microbix Biosystems Inc.
MBX.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -32.13% | -11.19% | -30.13% | 45.15% | -10.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -32.13% | -11.19% | -30.13% | 45.15% | -10.18% |
| Cost of Revenue | -11.98% | -23.90% | 1.90% | -1.50% | -28.80% |
| Gross Profit | -49.08% | 0.19% | -41.39% | 138.07% | 15.15% |
| SG&A Expenses | 3.49% | 15.57% | -33.03% | 14.61% | -18.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.70% | -6.56% | -15.53% | 4.48% | -21.87% |
| Operating Income | -1,128.91% | -63.44% | -63.31% | 170.56% | 118.82% |
| Income Before Tax | -758.51% | -94.86% | -66.08% | -70.91% | 131.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -758.51% | -94.86% | -66.08% | -78.32% | 131.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -758.51% | -94.86% | -66.08% | -78.32% | 131.49% |
| EBIT | -1,128.91% | -63.44% | -63.31% | 170.56% | 118.82% |
| EBITDA | -257.82% | -33.98% | -56.32% | 217.26% | 250.19% |
| EPS Basic | -746.15% | -95.00% | -65.91% | -77.98% | 130.95% |
| Normalized Basic EPS | -1,866.67% | -92.31% | -66.27% | 167.57% | 111.54% |
| EPS Diluted | -769.23% | -95.00% | -67.42% | -77.98% | 128.89% |
| Normalized Diluted EPS | -1,866.67% | -92.31% | -66.27% | 167.57% | 111.54% |
| Average Basic Shares Outstanding | 2.73% | 1.80% | -1.10% | -0.51% | -0.51% |
| Average Diluted Shares Outstanding | 2.17% | 1.08% | -0.63% | 0.03% | 0.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |